Cavu Biotherapies, Inc. reported raising $50,000 in an initial SEC Form D filing, from an offering of $1.5 Million
Amount Raised
$50,000
Round Type
Pre-Seed
HoustonBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as CAVU Biotherapies, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Arrakis Therapeutics, Inc. raised $15M on April 18, 2019.
- InGeneron, Inc. raised $3.5M (Seed) on April 18, 2019.
- TendoNova raised $200K (Pre-Seed) on April 18, 2019.
- Korsana Biosciences raised $175M on April 17, 2019.
- Trethera raised $581K (Seed) on April 17, 2019.
- PathAI raised $60M on April 17, 2019.
Who to call at CAVU Biotherapies, Inc., and when
A new round usually means CAVU Biotherapies, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day CAVU Biotherapies, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at CAVU Biotherapies, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at CAVU Biotherapies, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment CAVU Biotherapies, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
CAVU Biotherapies, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.